These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28945702)

  • 21. Hypoxic preconditioning improves the survival and pro-angiogenic capacity of transplanted human umbilical cord mesenchymal stem cells via HIF-1α signaling in a rat model of bronchopulmonary dysplasia.
    Hao C; You J; Qiu H; Zhou O; Liu J; Zou W; Yang K; Fu Z; Zou L
    Biochem Biophys Res Commun; 2022 May; 605():111-118. PubMed ID: 35316761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to introduce MSC-based therapy for the developing lung safely into clinical care?
    Rüdiger M; Kirpalani H; Steinhorn R; Davis JM; Thebaud B
    Pediatr Res; 2020 Sep; 88(3):365-368. PubMed ID: 31931507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem/Progenitor Cells and Related Therapy in Bronchopulmonary Dysplasia.
    Marega M; El-Merhie N; Gökyildirim MY; Orth V; Bellusci S; Chao CM
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential therapeutic effect of human umbilical cord mesenchymal stem cell-derived exosomes in bronchopulmonary dysplasia.
    Cheng T; Mao M; Liu Y; Xie L; Shi F; Liu H; Li X
    Life Sci; 2024 Nov; 357():123047. PubMed ID: 39260518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.
    Augustine S; Avey MT; Harrison B; Locke T; Ghannad M; Moher D; Thébaud B
    Stem Cells Transl Med; 2017 Dec; 6(12):2079-2093. PubMed ID: 29045045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension.
    Suzuki T; Sato Y; Yamamoto H; Kato T; Kitase Y; Ueda K; Mimatsu H; Sugiyama Y; Onoda A; Saito S; Takahashi Y; Nakayama T; Hayakawa M
    Cytotherapy; 2020 Apr; 22(4):180-192. PubMed ID: 32139242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia.
    Lesage F; Thébaud B
    Semin Perinatol; 2018 Nov; 42(7):453-458. PubMed ID: 30376986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mesenchymal stem cell transplantation in the treatment of bronchopulmonary dysplasia: opportunities and challenges].
    Bao L; Shi Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jul; 21(7):619-623. PubMed ID: 31315757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis and treatment of bronchopulmonary dysplasia.
    Gien J; Kinsella JP
    Curr Opin Pediatr; 2011 Jun; 23(3):305-13. PubMed ID: 21494147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances in Bronchopulmonary Dysplasia.
    Shukla VV; Ambalavanan N
    Indian J Pediatr; 2021 Jul; 88(7):690-695. PubMed ID: 34018135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in understanding and management of bronchopulmonary dysplasia.
    Sahni M; Bhandari V
    F1000Res; 2020; 9():. PubMed ID: 32704351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An experimental animal model of bronchopulmonary dysplasia: Secondary publication.
    Namba F
    Pediatr Int; 2021 May; 63(5):504-509. PubMed ID: 33465831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchopulmonary dysplasia: structural challenges and stem cell treatment potential.
    Niver D
    Adv Neonatal Care; 2014 Feb; 14(1):E1-E11. PubMed ID: 24472891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia.
    Tropea KA; Leder E; Aslam M; Lau AN; Raiser DM; Lee JH; Balasubramaniam V; Fredenburgh LE; Alex Mitsialis S; Kourembanas S; Kim CF
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L829-37. PubMed ID: 22328358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell biology and regenerative medicine for neonatal lung diseases.
    Kang M; Thébaud B
    Pediatr Res; 2018 Jan; 83(1-2):291-297. PubMed ID: 28922348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The promise of stem cells in bronchopulmonary dysplasia.
    O'Reilly M; Thébaud B
    Semin Perinatol; 2013 Apr; 37(2):79-84. PubMed ID: 23582961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study.
    Lim R; Malhotra A; Tan J; Chan ST; Lau S; Zhu D; Mockler JC; Wallace EM
    Stem Cells Transl Med; 2018 Sep; 7(9):628-635. PubMed ID: 30078207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia.
    Pierro M; Ionescu L; Montemurro T; Vadivel A; Weissmann G; Oudit G; Emery D; Bodiga S; Eaton F; Péault B; Mosca F; Lazzari L; Thébaud B
    Thorax; 2013 May; 68(5):475-84. PubMed ID: 23212278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lung development and mesenchymal stem cells].
    Waszak P; Thébaud B
    Arch Pediatr; 2011 Jul; 18 Suppl 2():S86-91. PubMed ID: 21763980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial.
    Ahn SY; Chang YS; Lee MH; Sung SI; Lee BS; Kim KS; Kim AR; Park WS
    Stem Cells Transl Med; 2021 Aug; 10(8):1129-1137. PubMed ID: 33876883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.